Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Asymmetric Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113980053A discloses novel chiral thioether-phosphine ligands enabling efficient palladium-catalyzed asymmetric allylic alkylation with high yields.
Patent CN101525291A details a water-based organocatalytic route for chiral bicyclics, offering high enantioselectivity and reduced environmental impact for pharmaceutical manufacturing.
Novel 5-step synthesis route for chiral phenylglycine catalysts. High yield, mild conditions, scalable for pharma intermediates.
Novel synthesis of chiral (R)-alpha-phenylethylamine acetate via cobalt complex. High yield Henry reaction catalyst for pharmaceutical intermediates manufacturing.
Patent CN116178431A discloses advanced N,N,P ligands enabling high enantioselectivity in radical reactions. Discover cost-effective synthesis and supply chain advantages for pharma intermediates.
Patent CN101142164B details a cost-effective route to Synthon A using planar chiral diphosphine catalysts, offering high ee and scalability for API manufacturing.
Patent CN102766058A details a novel organocatalytic route for photoactive alpha-amino acids, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel axon-labile chiral ligands enable efficient asymmetric catalysis without resolution. Reduces cost and waste in pharmaceutical intermediate manufacturing.
Patent CN103483363A reveals a novel Cu-NHC catalyzed route for diverse chiral aminoboronic acids, offering high stereoselectivity and simplified manufacturing for API intermediates.
Patent CN102731478A details a high-yield asymmetric oxidation route for Dexlansoprazole intermediates, offering superior optical purity and scalable manufacturing capabilities for global supply chains.
Patent CN114605272A details a novel Nickel-catalyzed asymmetric hydrogenation route for (R)-Fluoxetine intermediates, offering significant cost reduction and high enantioselectivity for API manufacturing.
Patent CN103483267A discloses a versatile arylimidazole catalyst enabling high-yield, glove-box-free synthesis of chiral alpha-amino boronic acid intermediates.
Patent CN112142790B reveals advanced chiral PCP pincer complexes enabling high-efficiency asymmetric catalysis for reliable pharmaceutical intermediate supply chains.
Patent CN108409746B details a novel chiral phosphoric acid catalyzed synthesis of spirooxindoles, offering a metal-free route for reliable pharmaceutical intermediate suppliers.
Patent CN120923476A reveals a 2-step Ni-catalyzed route for Orforglipron intermediates, eliminating SFC resolution and enabling cost-effective manufacturing.
Patent CN116875576B reveals mutant LeuDH for L-phenylglycine. Offers high conversion, ee >99%, and scalable biocatalysis for pharmaceutical supply chains.
Patent CN100376681C details a microbial asymmetric reduction method for (R)-mandelic acid using Saccharomyces cerevisiae, offering a green, cost-effective alternative to traditional chemical resolution for pharmaceutical manufacturing.
Patent CN112961194A discloses novel tridentate PNO ligands enabling high ee and yield in ketone hydrogenation, offering robust supply chain solutions for pharma intermediates.
Advanced synthesis of 1-carboxamido-1-cyclopropanecarboxylic acid via mild ammoniation. High-yield agrochemical intermediate for plant growth regulation and supply chain optimization.
Patent CN103570600B reveals Pd-catalyzed asymmetric amination for chiral beta-lactams. Enables cost reduction in pharmaceutical manufacturing with high enantioselectivity.